Home » Topics » BioWorld Science

BioWorld Science
RSS

Albireo initiates dosing in key clinical studies with two of its candidates

March 29, 2021

PepGen develops enhanced delivery oligonucleotides for muscular dystrophy

March 29, 2021

Anaveon gains CTA clearance for phase I/II study of ANV-419 in advanced solid tumors

March 26, 2021

Chinese phase III trial of LY-03005 for major depressive disorder meets endpoints

March 26, 2021

FDA accepts IND for phase Ib study of AT-100 for bronchopulmonary dysplasia

March 26, 2021

Sorrento reports further phase Ib data on COVI-MSC for COVID-19-induced ARDS

March 26, 2021

First-in-human data presented for SRP-9003 in patients with limb girdle muscular dystrophy type 2E

March 26, 2021

FDA approves Myrbetriq tablets and granules for neurogenic detrusor overactivity in children

March 26, 2021

Depletion of DNA polymerase beta increases platinum sensitivity in epithelial ovarian cancers

March 26, 2021

Multiple dosing of Lassa fever candidate LHF-535 well tolerated in healthy subjects

March 26, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...